Jade Biosciences, Inc.

Healthcare · Biotechnology · United States

Last price 14.24 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 905.63M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.